| Tretinoin | Approved Investigational Nutraceutical | ADORA2B | 136 |
downregulated | Tretinoin results in decreased expression of ADORA2B mRNA | 17p12 | |
| Tretinoin | Approved Investigational Nutraceutical | ADRA1B | 147 |
upregulated | Tretinoin results in increased expression of ADRA1B mRNA | 5q33.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ADRA2A | 150 |
upregulated | Tretinoin results in increased expression of ADRA2A mRNA | 10q25.2 | |
| Tretinoin | Approved Investigational Nutraceutical | ADRA2C | 152 |
downregulated | Tretinoin results in decreased expression of ADRA2C mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ADRA2C | 152 |
upregulated | Tretinoin results in increased expression of ADRA2C mRNA | 4p16.3 | |
| Tretinoin | Approved Investigational Nutraceutical | ADRB2 | 154 |
downregulated | Tretinoin results in decreased expression of ADRB2 mRNA | 5q32 | |
| Tretinoin | Approved Investigational Nutraceutical | ADRB2 | 154 |
upregulated | Tretinoin results in increased expression of ADRB2 mRNA | 5q32 | |
| Tretinoin | Approved Investigational Nutraceutical | AES | 166 |
upregulated | Tretinoin results in increased expression of AES mRNA | 19p13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AFAP1 | 60312 |
downregulated | Tretinoin results in decreased expression of AFAP1 mRNA | 4p16.1 | |
| Tretinoin | Approved Investigational Nutraceutical | AFAP1 | 60312 |
upregulated | Tretinoin results in increased expression of AFAP1 mRNA | 4p16.1 | |
| Tretinoin | Approved Investigational Nutraceutical | AFAP1L2 | 84632 |
upregulated | Tretinoin results in increased expression of AFAP1L2 mRNA | 10q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AFF3 | 3899 |
upregulated | Tretinoin results in increased expression of AFF3 mRNA | 2q11.2 | |
| Tretinoin | Approved Investigational Nutraceutical | AFP | 174 |
upregulated | Tretinoin results in increased expression of AFP mRNA | 4q13.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AFTPH | 54812 |
upregulated | Tretinoin results in increased expression of AFTPH mRNA | 2p14 | |
| Tretinoin | Approved Investigational Nutraceutical | AGMAT | 79814 |
downregulated | Tretinoin results in decreased expression of AGMAT mRNA | 1p36.21 | |
| Tretinoin | Approved Investigational Nutraceutical | AGO1 | 26523 |
upregulated | Tretinoin results in increased expression of AGO1 mRNA | 1p34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AGO4 | 192670 |
upregulated | Tretinoin results in increased expression of AGO4 mRNA | 1p34.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AGPAT3 | 56894 |
upregulated | Tretinoin results in increased expression of AGPAT3 mRNA | 21q22.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AGPS | 8540 |
downregulated | Tretinoin results in decreased expression of AGPS mRNA | 2q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | AGTPBP1 | 23287 |
upregulated | Tretinoin results in increased expression of AGTPBP1 mRNA | 9q21.33 | |
| Tretinoin | Approved Investigational Nutraceutical | AGTR1 | 185 |
downregulated | Tretinoin results in decreased expression of AGTR1 mRNA | 3q24 | |
| Tretinoin | Approved Investigational Nutraceutical | AGTR1 | 185 |
upregulated | Tretinoin results in increased expression of AGTR1 mRNA | 3q24 | |
| Tretinoin | Approved Investigational Nutraceutical | AHNAK | 79026 |
downregulated | Tretinoin results in decreased expression of AHNAK mRNA | 11q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AHNAK | 79026 |
upregulated | Tretinoin results in increased expression of AHNAK mRNA | 11q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | AHR | 196 |
downregulated | Tretinoin results in decreased expression of AHR mRNA | 7p21.1 | |